Preparing for Future Viral Outbreaks in a Global Community
Ambassador Deborah Birx, MD, believes not enough is doing to prepare for future pandemics. What are her recommendations? Find out in this final installment of her interview with Infection Control Today.
After SARS-CoV-2, researchers are concerned about preparing for the next viral outbreak and where the virus will come from. Infectious diseases do not stay isolated for long in modern times because we are a global community. How we prepare for future outbreaks—even pandemics—will require testing, treatment, prevention, and vaccinations worldwide.
Speaking in an exclusive interview with Infection Control Today® (ICT®) Ambassador Deborah Birx, MD, discussed her presentation titled, “COVID-19 USA - Lessons and new tools to improve workplace safety" at the "Frontline Worker Safety in the Age of COVID-19: A Global Perspective” a Health Watch USA Webinar on September 14, 2022. In this final installment of the interview, she also expressed her concerns about how future viruses may spread from more tropical climates to wider areas because of climate change and how the world should prepare for them.
Ambassador Deborah Birx, MD
Birx is a world-renowned medical expert whose long career has focused on clinical and basic immunology, infectious disease, pandemic preparedness, vaccine research, and global health.
She served the United States as an Army Colonel and later, running some of the most high-profile and influential programs at the US Centers for Disease Control and Prevention and US Department of State. Birx served as the White House Coronavirus Response Coordinator during the Trump Administration.
“With increasing temperatures, many of these viruses that were isolated to tropical areas may become prominent, and from what were semi-tropical, or even temperate climates,” Birx told ICT®. “This is a deep concern because as a global population, we have worked so hard to improve treatment to cancer, [and] we've ignored viral diseases, both from their diagnostics and their treatment…we're not making investments for the medium term; we can see that all of these diseases are escalating as climate changes, as the more importantly, as the human population interacts.”
This is the fourth of 4 installments.
The first installment of the interview is here.
The second installment of the interview is here.
The third installment of the interview is here.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.
Infection Intel: Revolutionizing Ultrasound Probe Disinfection With Germitec's Chronos
November 19th 2024Learn how Germitec’s Chronos uses patented UV-C technology for high-level disinfection of ultrasound probes in 90 seconds, enhancing infection control, patient safety, and environmental sustainability.
CDC HICPAC Considers New Airborne Pathogen Guidelines Amid Growing Concerns
November 18th 2024The CDC HICPAC discussed updates to airborne pathogen guidelines, emphasizing the need for masks in health care. Despite risks, the committee resisted universal masking, highlighting other mitigation strategies
